Brief Information of the Cell Line and Protein
Cell Line ID: CL000246 , NCI-H292
Synonyms
H292
H-292
NCI-HUT-292
Hut292
NCIH292
Category Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0455
Protein ID: PT00967 , Glucocorticoid receptor
Gene Name NR3C1
Organism Homo sapiens, Human
Protein Classification Transcription factor
Uniprot ID P04150
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000246  Protein ID: PT00967
 
Compound ID Compound Name Compound Formula
CP0070809
CCI-18781
   Show/Hide
C25H31F3O5S
 1
1
IC50 = 0.075 nM
   TI
   LI
   LO
   TS
CP0400170
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-([1,3]oxazolo[4,5-b]pyridin-2-ylsulfanyl)ethanone
   Show/Hide
C34H35FN4O4S
 1
1
IC50 = 0.32 nM
   TI
   LI
   LO
   TS
CP0416607
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-hydroxyethanone
   Show/Hide
C28H33FN2O4
 1
1
IC50 = 0.4 nM
   TI
   LI
   LO
   TS
CP0380981
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-pyridin-2-ylsulfanylethanone
   Show/Hide
C33H36FN3O3S
 1
1
IC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0416609
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-pyrimidin-2-ylsulfanylethanone
   Show/Hide
C32H35FN4O3S
 1
1
IC50 = 0.6 nM
   TI
   LI
   LO
   TS
CP0416614
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-hydroxyethanone
   Show/Hide
C28H34N2O4
 1
1
IC50 = 0.63 nM
   TI
   LI
   LO
   TS
CP0400160
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-naphthalen-2-ylsulfanylethanone
   Show/Hide
C38H39FN2O3S
 1
1
IC50 = 0.72 nM
   TI
   LI
   LO
   TS
CP0393622
[(8S,9S,10R,11S,13S,14S,17R)-17-[2-(1,3-benzothiazol-2-ylsulfanyl)acetyl]-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
   Show/Hide
C33H33NO6S2
 1
1
IC50 = 0.75 nM
   TI
   LI
   LO
   TS
CP0400175
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-([1,3]oxazolo[4,5-b]pyridin-2-ylsulfanyl)ethanone
   Show/Hide
C34H36N4O4S
 1
1
IC50 = 0.89 nM
   TI
   LI
   LO
   TS
CP0388379
[(8S,9S,10R,11S,13S,14S,17R)-17-[2-[(4,5-dimethyl-1,3-thiazol-2-yl)sulfanyl]acetyl]-11-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
   Show/Hide
C31H37NO6S2
 1
1
IC50 = 0.9 nM
   TI
   LI
   LO
   TS
CP0416608
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-naphthalen-2-yloxyethanone
   Show/Hide
C38H39FN2O4
 1
1
IC50 = 1.06 nM
   TI
   LI
   LO
   TS
CP0410216
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-(1-methylbenzimidazol-2-yl)sulfanylethanone
   Show/Hide
C36H39FN4O3S
 1
1
IC50 = 1.1 nM
   TI
   LI
   LO
   TS
CP0393621
[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-10,13-dimethyl-3-oxo-17-(2-quinoxalin-2-ylsulfanylacetyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
   Show/Hide
C34H36N2O6S
 1
1
IC50 = 1.4 nM
   TI
   LI
   LO
   TS
CP0400174
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-pyridin-2-ylsulfanylethanone
   Show/Hide
C33H37N3O3S
 1
1
IC50 = 1.5 nM
   TI
   LI
   LO
   TS
CP0088196
(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C22H30O5
 1
1
IC50 = 1.6 nM
   TI
   LI
   LO
   TS
CP0380980
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-isoquinolin-1-ylsulfanylethanone
   Show/Hide
C37H38FN3O3S
 1
1
IC50 = 1.6 nM
   TI
   LI
   LO
   TS
CP0418766
(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-17-[2-(6-methylpyridin-2-yl)sulfanylacetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C28H35NO4S
 1
1
IC50 = 1.69 nM
   TI
   LI
   LO
   TS
CP0400172
2-(1,3-benzothiazol-2-ylsulfanyl)-1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]ethanone
   Show/Hide
C35H36FN3O3S2
 1
1
IC50 = 1.7 nM
   TI
   LI
   LO
   TS
CP0432419
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-quinolin-2-yloxyethanone
   Show/Hide
C37H38FN3O4
 1
1
IC50 = 1.8 nM
   TI
   LI
   LO
   TS
CP0432422
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-quinoxalin-2-yloxyethanone
   Show/Hide
C36H37FN4O4
 1
1
IC50 = 1.89 nM
   TI
   LI
   LO
   TS
CP0238565
(6S,8S,9R,10S,11S,13S,14S,16R,17R)-17-[2-(1,3-benzothiazol-2-ylsulfanyl)acetyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
   Show/Hide
C29H31F2NO4S2
 1
1
IC50 = 1.9 nM
   TI
   LI
   LO
   TS
CP0513436
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-quinoxalin-2-ylsulfanylethanone
   Show/Hide
C36H37FN4O3S
 1
1
IC50 = 1.99 nM
   TI
   LI
   LO
   TS
CP0492605
[(8S,9S,10R,11S,13S,14S,17R)-17-[2-(1,3-benzothiazol-2-ylsulfanyl)acetyl]-11-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
   Show/Hide
C33H35NO6S2
 1
1
IC50 = 2 nM
   TI
   LI
   LO
   TS
CP0390323
[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-10,13-dimethyl-17-[2-(4-methylpyrimidin-2-yl)sulfanylacetyl]-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
   Show/Hide
C31H34N2O6S
 1
1
IC50 = 2.1 nM
   TI
   LI
   LO
   TS
CP0496091
[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-isoquinolin-1-ylsulfanylacetyl)-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
   Show/Hide
C35H35NO6S
 1
1
IC50 = 2.1 nM
   TI
   LI
   LO
   TS
CP0385331
2-(1,3-benzothiazol-2-yloxy)-1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]ethanone
   Show/Hide
C35H36FN3O4S
 1
1
IC50 = 2.1 nM
   TI
   LI
   LO
   TS
CP0390324
[(8S,9S,10R,11S,13S,14S,17R)-17-[2-(1,3-benzoxazol-2-ylsulfanyl)acetyl]-11-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
   Show/Hide
C33H35NO7S
 1
1
IC50 = 2.2 nM
   TI
   LI
   LO
   TS
CP0432416
1-[(1S,2R,13S,14S,17R,18S,20S)-7-cyclohexyl-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-hydroxyethanone
   Show/Hide
C28H40N2O4
 1
1
IC50 = 2.37 nM
   TI
   LI
   LO
   TS
CP0446952
1-[(1S,2R,13S,14S,17R,18S,20S)-7-cyclohexyl-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-[(4,5-dimethyl-1,3-thiazol-2-yl)sulfanyl]ethanone
   Show/Hide
C33H45N3O3S2
 1
1
IC50 = 2.8 nM
   TI
   LI
   LO
   TS
CP0390321
[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-10,13-dimethyl-3-oxo-17-(2-quinolin-2-ylsulfanylacetyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
   Show/Hide
C35H37NO6S
 1
1
IC50 = 2.85 nM
   TI
   LI
   LO
   TS
CP0416612
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-(1-methylbenzimidazol-2-yl)oxyethanone
   Show/Hide
C36H39FN4O4
 1
1
IC50 = 2.9 nM
   TI
   LI
   LO
   TS
CP0385328
2-[2-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-oxoethyl]sulfanyl-3H-quinazolin-4-one
   Show/Hide
C36H37FN4O4S
 1
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
CP0428604
2-(1,3-benzoxazol-2-ylsulfanyl)-1-[(1S,2R,13S,14S,17R,18S,20S)-7-cyclohexyl-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]ethanone
   Show/Hide
C35H43N3O4S
 1
1
IC50 = 3.12 nM
   TI
   LI
   LO
   TS
CP0434913
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone
   Show/Hide
C38H42N4O3S
 1
1
IC50 = 3.43 nM
   TI
   LI
   LO
   TS
CP0388380
[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-10,13-dimethyl-17-[2-(1-methylbenzimidazol-2-yl)sulfanylacetyl]-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
   Show/Hide
C34H38N2O6S
 1
1
IC50 = 3.7 nM
   TI
   LI
   LO
   TS
CP0454914
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-quinoxalin-2-yloxyethanone
   Show/Hide
C36H38N4O4
 1
1
IC50 = 3.7 nM
   TI
   LI
   LO
   TS
CP0283298
(8S,9R,10S,11S,13S,14S,16R,17R)-17-[2-(1,3-benzothiazol-2-ylsulfanyl)acetyl]-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
   Show/Hide
C29H32FNO4S2
 1
1
IC50 = 4.4 nM
   TI
   LI
   LO
   TS
CP0393735
(8S,9S,10R,11S,13S,14S,16R,17R)-17-[2-(1,3-benzoxazol-2-ylsulfanyl)acetyl]-11,17-dihydroxy-10,13,16-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C29H33NO5S
 1
1
IC50 = 4.4 nM
   TI
   LI
   LO
   TS
CP0452475
1-[(1S,2R,13S,14S,17R,18S,20S)-7-cyclohexyl-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-pyridin-2-ylsulfanylethanone
   Show/Hide
C33H43N3O3S
 1
1
IC50 = 4.4 nM
   TI
   LI
   LO
   TS
CP0410217
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-(1-methylbenzimidazol-2-yl)sulfanylethanone
   Show/Hide
C36H40N4O3S
 1
1
IC50 = 4.7 nM
   TI
   LI
   LO
   TS
CP0336358
(8S,9R,10S,11S,13S,14S,16R,17R)-17-[2-(1,3-benzothiazol-2-ylsulfanyl)acetyl]-9-chloro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
   Show/Hide
C29H32ClNO4S2
 1
1
IC50 = 4.95 nM
   TI
   LI
   LO
   TS
CP0427353
(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-17-[2-[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C30H34N2O5S
 1
1
IC50 = 5.1 nM
   TI
   LI
   LO
   TS
CP0400173
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-quinolin-2-ylsulfanylethanone
   Show/Hide
C37H38FN3O3S
 1
1
IC50 = 5.3 nM
   TI
   LI
   LO
   TS
CP0416610
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-quinoxalin-2-ylsulfanylethanone
   Show/Hide
C36H38N4O3S
 1
1
IC50 = 5.36 nM
   TI
   LI
   LO
   TS
CP0387984
(8S,9S,10R,11S,13S,14S,16R,17R)-17-[2-(1,3-benzothiazol-2-ylsulfanyl)acetyl]-11,17-dihydroxy-10,13,16-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C29H33NO4S2
 1
1
IC50 = 5.8 nM
   TI
   LI
   LO
   TS
CP0401463
(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-17-[2-([1,3]oxazolo[4,5-b]pyridin-2-ylsulfanyl)acetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C28H32N2O5S
 1
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
CP0409039
1-[(1S,2R,13S,14S,17R,18S,20S)-7-cyclohexyl-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-(1-methylbenzimidazol-2-yl)sulfanylethanone
   Show/Hide
C36H46N4O3S
 1
1
IC50 = 6.6 nM
   TI
   LI
   LO
   TS
CP0432716
(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-17-[2-([1,3]thiazolo[5,4-b]pyridin-2-ylsulfanyl)acetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C28H32N2O4S2
 1
1
IC50 = 7 nM
   TI
   LI
   LO
   TS
CP0400171
2-(1,3-benzothiazol-2-ylsulfanyl)-1-[(1S,2R,13S,14S,17R,18S,20S)-7-cyclohexyl-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]ethanone
   Show/Hide
C35H43N3O3S2
 1
1
IC50 = 7.1 nM
   TI
   LI
   LO
   TS
CP0400176
1-[(1S,2R,13S,14S,17R,18S,20S)-7-cyclohexyl-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-pyrimidin-2-ylsulfanylethanone
   Show/Hide
C32H42N4O3S
 1
1
IC50 = 7.3 nM
   TI
   LI
   LO
   TS
CP0380940
2-(1,3-benzothiazol-2-ylsulfanyl)-1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]ethanone
   Show/Hide
C35H37N3O3S2
 1
1
IC50 = 7.5 nM
   TI
   LI
   LO
   TS
CP0047174
(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one
   Show/Hide
C21H28O5
 1
1
IC50 = 7.7 nM
   TI
   LI
   LO
   TS
CP0395062
[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-10,13-dimethyl-3-oxo-17-(2-pyrimidin-2-ylsulfanylacetyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
   Show/Hide
C30H34N2O6S
 1
1
IC50 = 9.7 nM
   TI
   LI
   LO
   TS
CP0392038
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-[2-(4-methylpyrimidin-2-yl)sulfanylacetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C26H32N2O4S
 1
1
IC50 = 11.4 nM
   TI
   LI
   LO
   TS
CP0416611
1-[(1S,2R,13S,14S,17R,18S,20S)-7-cyclohexyl-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-quinoxalin-2-ylsulfanylethanone
   Show/Hide
C36H44N4O3S
 1
1
IC50 = 12.4 nM
   TI
   LI
   LO
   TS
CP0393724
(8S,9S,10R,11S,13S,14S,17R)-17-[2-(1,3-benzoxazol-2-ylsulfanyl)acetyl]-11,17-dihydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C28H31NO5S
 1
1
IC50 = 13.5 nM
   TI
   LI
   LO
   TS
CP0388451
[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-10,13-dimethyl-3-oxo-17-[2-([1,3]thiazolo[4,5-b]pyridin-2-ylsulfanyl)acetyl]-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
   Show/Hide
C32H34N2O6S2
 1
1
IC50 = 14.3 nM
   TI
   LI
   LO
   TS
CP0400177
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-quinolin-2-ylsulfanylethanone
   Show/Hide
C37H39N3O3S
 1
1
IC50 = 14.8 nM
   TI
   LI
   LO
   TS
CP0390322
[(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-isoquinolin-1-ylsulfanylacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
   Show/Hide
C35H37NO6S
 1
1
IC50 = 15.9 nM
   TI
   LI
   LO
   TS
CP0387979
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-[2-([1,3]oxazolo[4,5-b]pyridin-2-ylsulfanyl)acetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C27H30N2O5S
 1
1
IC50 = 17.2 nM
   TI
   LI
   LO
   TS
CP0393729
(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-17-(2-isoquinolin-1-ylsulfanylacetyl)-10,13,16-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C31H35NO4S
 1
1
IC50 = 17.6 nM
   TI
   LI
   LO
   TS
CP0203894
(8S,9R,10S,11S,13S,14S,17R)-17-[2-(1,3-benzothiazol-2-ylsulfanyl)acetyl]-9-fluoro-11,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
   Show/Hide
C28H32FNO4S2
 1
1
IC50 = 18.8 nM
   TI
   LI
   LO
   TS
CP0314892
(8S,9S,10R,11S,13S,14S,17R)-17-[2-[(4,5-dimethyl-1,3-thiazol-2-yl)sulfanyl]acetyl]-11,17-dihydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C26H35NO4S2
 1
1
IC50 = 21.9 nM
   TI
   LI
   LO
   TS
CP0154357
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-(2-quinoxalin-2-ylsulfanylacetyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C29H34N2O4S
 1
1
IC50 = 22.1 nM
   TI
   LI
   LO
   TS
CP0418767
(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-17-(2-quinazolin-4-ylsulfanylacetyl)-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C30H34N2O4S
 1
1
IC50 = 23.5 nM
   TI
   LI
   LO
   TS
CP0154358
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-(2-pyridin-2-ylsulfanylacetyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C26H33NO4S
 1
1
IC50 = 23.8 nM
   TI
   LI
   LO
   TS
CP0432415
(8S,9S,10R,11S,13S,14S,17R)-17-[2-(1,3-benzoxazol-2-ylsulfanyl)acetyl]-11,17-dihydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C28H33NO5S
 1
1
IC50 = 26.7 nM
   TI
   LI
   LO
   TS
CP0360939
(8S,9S,10R,11S,13S,14S,17R)-17-[2-(3,4-dichlorophenyl)sulfanylacetyl]-11,17-dihydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C27H32Cl2O4S
 1
1
IC50 = 27.2 nM
   TI
   LI
   LO
   TS
CP0315656
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-[2-[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetyl]-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C29H34N2O5S
 1
1
IC50 = 29.2 nM
   TI
   LI
   LO
   TS
CP0291663
(8S,9S,10R,11S,13S,14S,17R)-17-[2-(1,3-benzothiazol-2-ylsulfanyl)acetyl]-11,17-dihydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C28H31NO4S2
 1
1
IC50 = 35 nM
   TI
   LI
   LO
   TS
CP0074373
(8S,9S,10R,11S,13S,14S,17R)-17-[2-(1,3-benzothiazol-2-ylsulfanyl)acetyl]-11,17-dihydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C28H33NO4S2
 1
1
IC50 = 36 nM
   TI
   LI
   LO
   TS
CP0432715
(8S,9S,10R,11S,13S,14S,16R,17R)-17-[2-(1H-benzimidazol-2-ylsulfanyl)acetyl]-11,17-dihydroxy-10,13,16-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C29H34N2O4S
 1
1
IC50 = 36 nM
   TI
   LI
   LO
   TS
CP0478406
(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-17-(2-quinoxalin-2-ylsulfanylacetyl)-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C30H34N2O4S
 1
1
IC50 = 37.9 nM
   TI
   LI
   LO
   TS
CP0283480
(6S,8S,9S,10R,11S,13S,14S,17R)-17-[2-(1,3-benzothiazol-2-ylsulfanyl)acetyl]-11,17-dihydroxy-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C29H33NO4S2
 1
1
IC50 = 39.1 nM
   TI
   LI
   LO
   TS
CP0385433
(8S,9S,10R,11S,13S,14S,17R)-17-[2-(1-ethylbenzimidazol-2-yl)sulfanylacetyl]-11,17-dihydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C30H36N2O4S
 1
1
IC50 = 41.3 nM
   TI
   LI
   LO
   TS
CP0385431
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-(2-pyridin-2-ylsulfanylacetyl)-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C26H31NO4S
 1
1
IC50 = 43.8 nM
   TI
   LI
   LO
   TS
CP0450904
1-[(1S,2R,13S,14S,17R,18S,20S)-7-cyclohexyl-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-quinolin-2-ylsulfanylethanone
   Show/Hide
C37H45N3O3S
 1
1
IC50 = 44.7 nM
   TI
   LI
   LO
   TS
CP0387981
(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-17-(2-quinolin-2-ylsulfanylacetyl)-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C31H35NO4S
 1
1
IC50 = 46.5 nM
   TI
   LI
   LO
   TS
CP0145473
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-[2-(1-methylbenzimidazol-2-yl)sulfanylacetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C29H34N2O4S
 1
1
IC50 = 47 nM
   TI
   LI
   LO
   TS
CP0360938
(8R,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13,14-trimethyl-17-[2-(1-methylbenzimidazol-2-yl)sulfanylacetyl]-1,2,6,7,8,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-3-one
   Show/Hide
C30H38N2O4S
 1
1
IC50 = 56.1 nM
   TI
   LI
   LO
   TS
CP0392036
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-[2-(1H-imidazo[4,5-b]pyridin-2-ylsulfanyl)acetyl]-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C27H31N3O4S
 1
1
IC50 = 57.2 nM
   TI
   LI
   LO
   TS
CP0314894
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-[2-([1,3]thiazolo[4,5-b]pyridin-2-ylsulfanyl)acetyl]-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C27H32N2O4S2
 1
1
IC50 = 59.1 nM
   TI
   LI
   LO
   TS
CP0333116
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-[2-([1,3]oxazolo[4,5-b]pyridin-2-ylsulfanyl)acetyl]-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C27H32N2O5S
 1
1
IC50 = 61.3 nM
   TI
   LI
   LO
   TS
CP0418769
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-(2-quinazolin-2-ylsulfanylacetyl)-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C29H32N2O4S
 1
1
IC50 = 68.7 nM
   TI
   LI
   LO
   TS
CP0393728
(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-17-[2-(1-methylbenzimidazol-2-yl)sulfanylacetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C30H36N2O4S
 1
1
IC50 = 69.3 nM
   TI
   LI
   LO
   TS
CP0385432
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-(2-quinolin-2-ylsulfanylacetyl)-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C30H33NO4S
 1
1
IC50 = 70.2 nM
   TI
   LI
   LO
   TS
CP0410215
2-(1,3-benzothiazol-2-ylsulfanyl)-1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-(oxan-4-yl)-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]ethanone
   Show/Hide
C34H41N3O4S2
 1
1
IC50 = 86.4 nM
   TI
   LI
   LO
   TS
CP0146799
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-(2-quinolin-2-ylsulfanylacetyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C30H35NO4S
 1
1
IC50 = 89.3 nM
   TI
   LI
   LO
   TS
CP0380943
2-(1,3-benzothiazol-2-ylsulfanyl)-1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-7-(4-methoxyphenyl)-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]ethanone
   Show/Hide
C36H39N3O4S2
 1
1
IC50 = 107 nM
   TI
   LI
   LO
   TS
CP0387980
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-[2-([1,3]thiazolo[5,4-b]pyridin-2-ylsulfanyl)acetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C27H30N2O4S2
 1
1
IC50 = 118 nM
   TI
   LI
   LO
   TS
CP0154360
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-[2-(6-methylpyridin-2-yl)sulfanylacetyl]-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C27H35NO4S
 1
1
IC50 = 127 nM
   TI
   LI
   LO
   TS
CP0385329
2-(1,3-benzothiazol-2-ylsulfanyl)-1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-pyridin-2-yl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]ethanone
   Show/Hide
C34H36N4O3S2
 1
1
IC50 = 179 nM
   TI
   LI
   LO
   TS
CP0385434
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-[2-[(4-phenyl-1,3-thiazol-2-yl)sulfanyl]acetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C30H33NO4S2
 1
1
IC50 = 305 nM
   TI
   LI
   LO
   TS